Actionable news
0
All posts from Actionable news
Actionable news in INO: Inovio Pharmaceuticals, Inc.,

Inovio Pharmaceuticals to Present at Biotech Showcase

PLYMOUTH MEETING, Pa., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (INO) today announced that Dr. J. Joseph Kim, President and CEO, will give a corporate presentation on Tuesday, January 12th at 9:30AM PST at Biotech Showcase 2016. Dr. Kim will also participate on a Biotech Showcase panel entitled, Investing in the Immuno-Oncology Revolution: Follow the T Cells. This panel will occur on Wednesday, January 13th at 8:00AM PST and will feature additional leaders in the immuno-oncology space.

A live and archived version of Dr. Kim’s corporate presentation will be made available through the “Webcast” tab on Inovio’s home page at www.inovio.com as well as at the following URL: http://bit.ly/1O5Z6IE.

About Inovio Pharmaceuticals, Inc.

Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that is generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates with relevant clinical outcomes with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include MedImmune, Roche, University of Pennsylvania, DARPA, GeneOne Life Science, Drexel University, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and University of Manitoba. For more information...


More